BOTWOOD NICHOLAS A.J. enters SYNDAX PHARMACEUTICALS INC with 23.40K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/16/2025ACC: 0000950170-25-073559
Officer· Head of R&D, CMO
Since Feb 2026
23.40K
Baseline shares
100% direct
23.40K
Direct ownership
1 position
215K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned23.40K
Total
23.40K direct23.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 23.40K | Direct |
| Total | 23.40K | 23.40K direct |
Derivative Holdings1
Stock Options (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
215K
Shares owned
N/A
Exercise price
13.82
Expiration
—
Exercise window
—
Total
Underlying
215K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock | 13.82 | — | — | 215K | N/A |
| Total | 215K | 0.00 | ||||